PROLONGED RELEASE PREGABALIN (MisabriĀ®)

Clinical Indication

Comments

Not to be used across LLR.

Date of classification

February 2025

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.